Digest Network Come funziona
Network
/
Società
Ni
Non verificato

Niagen Bioscience, Inc

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza

39 comunicati stampa

Guarda tutti i comunicati
28/04/2026
Mercato del lavoro
Industria
Salute
Scienza
Sanità
Farmaceutica
Biotecnologia
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
22/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Comunicazione
Scienza
Sanità
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
09/04/2026
Mercato del lavoro
Industria
Salute
Fitness
Scienza
Farmaceutica
Biotecnologia
Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen®
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
31/03/2026
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
19/03/2026
Finanza
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience Increases Share Repurchase Program to $20 Million
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
18/03/2026
Eventi
Web e Social Network
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience to Present at the 38th Annual ROTH Conference
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
17/03/2026
Salute
Sanità
Fitness
Scienza
Biotecnologia
Industria
Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
10/03/2026
Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen®
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
04/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
26/02/2026
Organizzazione Aziendale
Salute
Fitness
Sanità
Farmaceutica
Biotecnologia
Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0